Who
Scott B. Willoughby
SVP, Chief Legal Officer, Secy
Company insider
Files Form 4 as: SVP, Chief Legal Officer, Secy, Sangamo Therapeutics.
In numbers
- Trades disclosed
- 48
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 13 Aug 2021
- Last trade
- 25 May 2026
- Last filed
- 27 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 May 2026filed 27 May 2026 | Sangamo TherapeuticsBiotechnology | SEC FORM 4 Code F | $7034,036 at $0.1743 | filing |
| 25 May 2026filed 27 May 2026 | Sangamo Therapeutics | SEC FORM 4 Code F | $6864,036 at $0.17 | filing |
| 1 Apr 2026filed 3 Apr 2026 | Sangamo Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —800,000 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | Sangamo Therapeuticsoption or derivative | SEC FORM 4 Code A | —800,000 at $0.00 | filing |
| 25 Feb 2026filed 26 Feb 2026 | Sangamo TherapeuticsBiotechnology | SEC FORM 4 Code F | $5,80612,354 at $0.47 | filing |
| 25 Feb 2026filed 26 Feb 2026 | Sangamo Therapeutics | SEC FORM 4 Code F | $5,80612,354 at $0.47 | filing |
| 24 Feb 2026filed 26 Feb 2026 | Sangamo TherapeuticsBiotechnology | SEC FORM 4 Code F | $7801,650 at $0.4725 | filing |
| 24 Feb 2026filed 26 Feb 2026 | Sangamo Therapeutics | SEC FORM 4 Code F | $7761,650 at $0.47 | filing |
| 22 Jan 2026filed 26 Jan 2026 | Sangamo TherapeuticsBiotechnology | SEC FORM 4 Code F | $15K36,676 at $0.3985 | filing |
| 22 Jan 2026filed 26 Jan 2026 | Sangamo Therapeutics | SEC FORM 4 Code F | $15K36,676 at $0.40 | filing |
| 24 Nov 2025filed 26 Nov 2025 | Sangamo Therapeutics | SEC FORM 4 Code F | $8552,035 at $0.42 | filing |
| 22 Oct 2025filed 24 Oct 2025 | Sangamo Therapeutics | SEC FORM 4 Code F | $29K44,122 at $0.66 | filing |
| 24 Aug 2025filed 26 Aug 2025 | Sangamo Therapeutics | SEC FORM 4 Code F | $8461,434 at $0.59 | filing |
| 22 Jul 2025filed 24 Jul 2025 | Sangamo Therapeutics | SEC FORM 4 Code F | $15K31,866 at $0.48 | filing |
| 24 May 2025filed 28 May 2025 | Sangamo Therapeutics | SEC FORM 4 Code F | $6741,433 at $0.47 | filing |
| 22 Apr 2025filed 24 Apr 2025 | Sangamo Therapeutics | SEC FORM 4 Code F | $25K31,866 at $0.78 | filing |
| 25 Feb 2025filed 26 Feb 2025 | Sangamo Therapeuticsoption or derivative | SEC FORM 4 Code A | —560,000 at $0.00 | filing |
| 25 Feb 2025filed 26 Feb 2025 | Sangamo Therapeutics | SEC FORM 4 Code F | $1,3201,375 at $0.96 | filing |
| 25 Feb 2025filed 26 Feb 2025 | Sangamo Therapeutics | SEC FORM 4 Code A | —120,000 at $0.00 | filing |
| 24 Feb 2025filed 26 Feb 2025 | Sangamo Therapeutics | SEC FORM 4 Code F | $1,4341,434 at $1.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.